保健医療経済評価研究センター
鈴木 裕太SUZUKI Yuta
専門分野
臨床疫学、医療経済学、腎臓リハビリテーション
人材育成
専門課程
1 地域保健臨床研修専攻科
短期研修
1 保健医療事業の経済的評価に関する研修 副主任
2 地域保健施策立案支援のための情報利活用に関する研修 副主任
研究実績
原著論文
1 Suzuki Y, Kaneko H, Azegami T, Okada A, Ko T, Fujiu K, Takeda N, Morita H, Yokoo T, Node K, Hayashi K, Komuro I, Yasunaga H, Nangaku M, Takeda N. Predicted Lean Body Mass and the Risk of Adverse Kidney Outcomes in Men. J Ren Nutr. 2026 Jan 16:S1051-2276(26)00001-4.
2 Suzuki Y, Shiroiwa T, Murata T, Kamono E, Morii Y, Fukuda T. Convergent validity, reliability and responsiveness of the AP-7D and EQ-5D-5L based on the survey for the general people in five countries: a new cultural-specific preference-based measure developed in east and southeast asia. Health Qual Life Outcomes. 2025 Jun 13;23(1):61.
3 Suzuki Y, Kaneko H, Okada A, Komuro J, Ko T, Fujiu K, Takeda N, Morita H, Nishiyama A, Ieda M, Node K, Yasunaga H, Nangaku M, Komuro I. Kidney outcomes with SGLT2 inhibitor versus DPP4 inhibitor use in older adults with diabetes. Nephrol Dial Transplant. 2025 Feb 28;40(3):495-504.
4 Suzuki Y, Hoshi K, Shiroiwa T, Fukuda T. Cost-effectiveness analysis of lifestyle interventions for preventing kidney disease in patients with type 2 diabetes. Clin Exp Nephrol. 2023 May 17.
5 Suzuki Y, Kaneko H, Yano Y, Okada A, Matsuoka S, Fujiu K, Michihata N, Jo T, Takeda N, Morita H, Node K, Yasunaga H, Komuro I. Reduction in blood pressure for people with isolated diastolic hypertension and cardiovascular outcomes. Eur J Prev Cardiol. 2023 Aug 1;30(10):928-934.
6 Suzuki Y, Kaneko H, Yano Y, Okada A, Itoh H, Ueno K, Matsuoka S, Fujiu K, Michihata N, Jo T, Takeda N, Morita H, Yokota I, Node K, Yasunaga H, Komuro I. Dose-dependent relationship of blood pressure and glycaemic status with risk of aortic dissection and aneurysm. Eur J Prev Cardiol. 2022 Dec 21;29(18):2338-2346.
7 Suzuki Y, Kaneko H, Okada A, Matsuoka S, Fujiu K, Michihata N, Jo T, Takeda N, Morita H, Node K, Nangaku M, Yasunaga H, Komuro I. Kidney outcomes in patients with diabetes mellitus did not differ between individual sodium-glucose cotransporter-2 inhibitors. Kidney Int. 2022 Nov;102(5):1147-1153.
8 Suzuki Y, Kaneko H, Okada A, Itoh H, Matsuoka S, Fujiu K, Michihata N, Jo T, Takeda N, Morita H, Kamiya K, Matsunaga A, Ako J, Node K, Yasunaga H, Komuro I. Comparison of cardiovascular outcomes between SGLT2 inhibitors in diabetes mellitus. Cardiovasc Diabetol. 2022 May 18;21(1):67.
9 Suzuki Y, Kaneko H, Okada A, Matsuoka S, Itoh H, Fujiu K, Michihata N, Jo T, Takeda N, Morita H, Yamaguchi S, Node K, Yamauchi T, Yasunaga H, Komuro I. Prediabetes in Young Adults and Its Association With Cardiovascular Health Metrics in the Progression to Diabetes. J Clin Endocrinol Metab. 2022 Jun 16;107(7):1843-1853.
10 Suzuki Y, Matsuzawa R, Kamiya K, Hoshi K, Harada M, Watanabe T, Shimoda T, Yamamoto S, Matsunaga Y, Yoshida A, Matsunaga A. Trajectory of Lean Body Mass Assessed Using the Modified Creatinine Index and Mortality in Hemodialysis Patients. Am J Kidney Dis. 2020 Feb;75(2):195-203.